Vu B - Search Results

1

Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration.

Choudhry V, Zhang MY, Harris I, Sidorov IA, Vu B, Dimitrov AS, Fouts T, Dimitrov DS. Choudhry V, et al. Among authors: vu b. Biochem Biophys Res Commun. 2006 Sep 29;348(3):1107-15. doi: 10.1016/j.bbrc.2006.07.163. Epub 2006 Aug 4. Biochem Biophys Res Commun. 2006. PMID: 16904645 Free PMC article.

2

Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning.

Zhang MY, Choudhry V, Sidorov IA, Tenev V, Vu BK, Choudhary A, Lu H, Stiegler GM, Katinger HW, Jiang S, Broder CC, Dimitrov DS. Zhang MY, et al. J Immunol Methods. 2006 Dec 20;317(1-2):21-30. doi: 10.1016/j.jim.2006.09.016. Epub 2006 Oct 16. J Immunol Methods. 2006. PMID: 17078964 Free PMC article.

3

A large library based on a novel (CH2) scaffold: identification of HIV-1 inhibitors.

Xiao X, Feng Y, Vu BK, Ishima R, Dimitrov DS. Xiao X, et al. Biochem Biophys Res Commun. 2009 Sep 18;387(2):387-92. doi: 10.1016/j.bbrc.2009.07.044. Epub 2009 Jul 15. Biochem Biophys Res Commun. 2009. PMID: 19615335 Free PMC article.

4

Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens.

Zhang MY, Vu BK, Choudhary A, Lu H, Humbert M, Ong H, Alam M, Ruprecht RM, Quinnan G, Jiang S, Montefiori DC, Mascola JR, Broder CC, Haynes BF, Dimitrov DS. Zhang MY, et al. J Virol. 2008 Jul;82(14):6869-79. doi: 10.1128/JVI.00033-08. Epub 2008 May 14. J Virol. 2008. PMID: 18480433 Free PMC article.

5

Structure of an isolated unglycosylated antibody C(H)2 domain.

Prabakaran P, Vu BK, Gan J, Feng Y, Dimitrov DS, Ji X. Prabakaran P, et al. Acta Crystallogr D Biol Crystallogr. 2008 Oct;64(Pt 10):1062-7. doi: 10.1107/S0907444908025274. Epub 2008 Sep 19. Acta Crystallogr D Biol Crystallogr. 2008. PMID: 18931413 Free PMC article.

6

Dynamics of antibody domains studied by solution NMR.

Vu BK, Walsh JD, Dimitrov DS, Ishima R. Vu BK, et al. Methods Mol Biol. 2009;525:533-43, xv. doi: 10.1007/978-1-59745-554-1_29. Methods Mol Biol. 2009. PMID: 19252840 Free PMC article.

7

Engineered human antibody constant domains with increased stability.

Gong R, Vu BK, Feng Y, Prieto DA, Dyba MA, Walsh JD, Prabakaran P, Veenstra TD, Tarasov SG, Ishima R, Dimitrov DS. Gong R, et al. J Biol Chem. 2009 May 22;284(21):14203-10. doi: 10.1074/jbc.M900769200. Epub 2009 Mar 23. J Biol Chem. 2009. PMID: 19307178 Free PMC article.

8

Impact of antibody framework residue VH-71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme.

Krauss J, Arndt MA, Zhu Z, Newton DL, Vu BK, Choudhry V, Darbha R, Ji X, Courtenay-Luck NS, Deonarain MP, Richards J, Rybak SM. Krauss J, et al. Among authors: vu bk. Br J Cancer. 2004 May 4;90(9):1863-70. doi: 10.1038/sj.bjc.6601759. Br J Cancer. 2004. PMID: 15150594 Free PMC article.

9

Efficient killing of CD22+ tumor cells by a humanized diabody-RNase fusion protein.

Krauss J, Arndt MA, Vu BK, Newton DL, Seeber S, Rybak SM. Krauss J, et al. Biochem Biophys Res Commun. 2005 Jun 3;331(2):595-602. doi: 10.1016/j.bbrc.2005.03.215. Biochem Biophys Res Commun. 2005. PMID: 15850802

10

Generation of a highly stable, internalizing anti-CD22 single-chain Fv fragment for targeting non-Hodgkin's lymphoma.

Arndt MA, Krauss J, Schwarzenbacher R, Vu BK, Greene S, Rybak SM. Arndt MA, et al. Int J Cancer. 2003 Dec 10;107(5):822-9. doi: 10.1002/ijc.11451. Int J Cancer. 2003. PMID: 14566834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

286 results

Search Page

Filters